<DOC>
	<DOCNO>NCT00622908</DOCNO>
	<brief_summary>To evaluate clinical microbial efficacy ISV-403 administer three time day ( TID ) 5 day compare vehicle three time day 5 day treatment bacterial conjunctivitis</brief_summary>
	<brief_title>Clinical Microbial Efficacy ISV403 Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<criteria>Must least one year age . Must signature subject legally authorize representative ( subject 18 year age ) inform Consent Form . Must signature subject Assent Form subject 6 17 year age . Must clinical diagnosis acute bacterial conjunctivitis exhibit purulent conjunctival discharge ( crusty sticky eyelid ) redness least one eye . A minimum score 1 present discharge minimum score 1 either bulbar palpebral conjunctival injection . Must pinholed visual acuity equal well 20/200 eye . Age appropriate visual acuity test perform . Every effort make obtain visual acuity measurement child . If visual acuity unobtainable child , investigator 's discretion meet inclusion criterion . Must willing discontinue contact lens wear duration study . Must willing avoid disallow medication study period . Must understand scope study include completion diary , willing follow instruction , able make require study visit . If subject female childbearing potential , must utilize reliable contraceptive method negative pregnancy test . Any uncontrolled systemic disease debilitate disease . Use topical ophthalmic solution include tear substitute within two hour study . Use ophthalmic topical antiinflammatory agent within 48 hour study . Subjects likely require antimicrobial therapy active respiratory tract infection , urinary tract infection , skin/soft tissue infection , otitis medium . Pregnant nursing female . Known hypersensitivity SS734 ingredient study medication . Known hypersensitivity fluoroquinolones ingredient study medication . Ocular surgery ( include laser surgery ) either eye within past six week . Subjects suspect viral allergic conjunctivitis ( i.e. , severe itch acute follicular conjunctivitis ) , disease condition could interfere efficacy safety evaluation study medication . Subjects suspect iritis ( i.e. , small pupil , pain , photophobia infect eye ) . History recurrent corneal erosion syndrome , either idiopathic secondary previous corneal trauma dry eye syndrome . Use antibiotic within 72 hour enrollment . Any active ulcerative keratitis , specifically epithelial loss great punctate keratitis Participation ophthalmic drug device research study within 30 day prior entry study . Subjects immune compromise .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>